Nefopam, ¿Útil para él dolor neuropático?
dc.contributor.author | Santiago Téllez Buitrago Ribero | |
dc.contributor.author | Omar Fernando Gomezese | |
dc.contributor.author | Andrea Gutiérrez | |
dc.date.accessioned | 2025-01-31T20:22:51Z | |
dc.date.available | 2025-01-31T20:22:51Z | |
dc.date.issued | 2024-06-04 | |
dc.description.abstract | Nefopam is a drug with very interesting pharmacological characteristics for the treatment of acute postoperative pain, but even more, as an understudied analgesic strategy for neuropathic pain. The present review article was proposed to perform a search with the MeSH terms in (PubMed) with the formula terms (nefopam [MeSH Terms]) AND (neuropathic pain [MeSH Terms]). In this way, a great void of medical literature on a molecule with a great potential for research was evidenced since the sixties in European countries, doctors like Basset and collaborators in 1969 as a potential antidepressant which owes its action in relation to its interaction with the inhibition of monoamine reuptake, suppressive effect on sodium voltage channels and an inhibitory activity on voltage-dependent calcium channels; so, it is a drug with a high likelihood to the antineuropathic ones. At present there are no recommendations or guidelines that support the use of Nefopam for the treatment of neuropathic pain and so it is interesting to make a review article that can examine the little literature found and allow to awaken the interest of clinical researchers to add an intravenous analgesic strategy for neuropathic pain. | |
dc.identifier.citation | DOI: 10.25237/revchilanestv53n5-06 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14595/850 | |
dc.language.iso | en | |
dc.publisher | Revista Chilena de Anestesia | |
dc.title | Nefopam, ¿Útil para él dolor neuropático? |